Musculoskeletal Disorders
📧 Sign up to get email alerts when something new happens for Musculoskeletal Disorders.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-06-17Clinical Trial Update: Musculoskeletal Problems and Strategies Developed by Physiotherapists to Cope With Them
Completed clinical trial assessing musculoskeletal problems and coping strategies developed by physiotherapists for workers with occupationa…
-
CLINICAL_TRIALS trial_result · 2024-06-11Clinical Trial Update: Body Schema Alterations in Musculoskeletal Disorders : Effect of Laterality
A completed clinical trial from University Hospital Angers examines body schema alterations in musculoskeletal disorders and how laterality …
-
FDA approval · 2024-01-22FDA Approved: CHLORZOXAZONE — Original Application (Cintex Services, LLC)
FDA approved the original application for CHLORZOXAZONE, a generic muscle relaxant, from Cintex Services, LLC.
-
FDA approval · 2023-08-09FDA Approved: CHLORZOXAZONE — Original Application (Rising Pharma Holdings, Inc.)
FDA approved Rising Pharma's original ANDA for chlorzoxazone (generic) as a muscle relaxant to relieve muscle spasm associated with acute mu…
-
FDA approval · 2023-06-12FDA Approved: METHOCARBAMOL — Original Application (FH2 PHARMA LLC)
FDA approved FH2 PHARMA LLC's original application for methocarbamol (generic) under the ANDA pathway.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2022-07-15FDA Approved: METHOCARBAMOL — Supplemental Application (Trifluent Pharma LLC)
The FDA approved a supplemental application for Methocarbamol filed by Trifluent Pharma LLC. This action updates the regulatory status of Me…
-
FDA approval · 2022-04-05FDA Approved: CHLORZOXAZONE — Original Application (Rising Pharma Holdings, Inc.)
FDA approved the original application for chlorzoxazone (a generic muscle relaxant) from Rising Pharma Holdings, Inc.
-
CLINICAL_TRIALS trial_result · 2022-02-15Clinical Trial Update: Virtual Reality for Pain Management in Orthopaedic Patients [NA]
Clinical trial completed evaluating virtual reality for pain management in musculoskeletal injuries; results posted in 2022.
-
FDA approval · 2022-02-08FDA Approved: PIROXICAM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Piroxicam submitted by Teva Pharmaceuticals USA, Inc.
-
CLINICAL_TRIALS trial_result · 2021-01-22Clinical Trial Update: Rates of Recovery From Strenuous Exercise in Physically Active Older Adults [NA]
Clinical trial update on recovery rates from strenuous exercise in physically active older adults; study terminated with results posted.
-
FDA approval · 2020-08-04FDA Approved: METHOCARBAMOL — Supplemental Application (Sagent Pharmaceuticals)
FDA approved a supplemental application for methocarbamol filed by Sagent Pharmaceuticals for the generic product. The action authorizes an …
-
FDA approval · 2020-07-14FDA Approved: METHOCARBAMOL — Supplemental Application (Granules Pharmaceuticals Inc.)
FDA approved a supplemental application for methocarbamol tablets from Granules Pharmaceuticals Inc.
-
FDA approval · 2020-07-02FDA Approved: METHOCARBAMOL — Supplemental Application (GENTEX PHARMA, LLC)
FDA approved a supplemental application for methocarbamol from Gentex Pharma, LLC. This action grants regulatory approval under the suppleme…
-
FDA approval · 2020-05-01FDA Approved: CARISOPRODOL — Supplemental Application (Westminster Pharmaceuticals, LLC)
The FDA approved a supplemental application for Carisoprodol submitted by Westminster Pharmaceuticals, LLC.
-
FDA approval · 2019-09-23FDA Approved: METAXALONE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for Metaxalone (METAXALONE) from Amneal Pharmaceuticals LLC under ANDA203399.
-
FDA approval · 2019-04-04FDA Approved: SOMA — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Soma (carisoprodol) submitted by Viatris Specialty LLC.
-
FDA approval · 2019-04-02FDA Approved: CARISOPRODOL — Supplemental Application (Vensun Pharmaceuticals, Inc.)
The FDA approved a supplemental application for carisoprodol from Vensun Pharmaceuticals, Inc., marking an approved change to the product's …
-
CLINICAL_TRIALS trial_result · 2019-03-13Clinical Trial Update: Comprehensive vs. Assisted Management of Mood and Pain Symptoms [NA]
Clinical trial comparing comprehensive versus assisted management of mood and pain symptoms has completed; results posted in 2019.
-
FDA approval · 2018-11-13FDA Approved: CARISOPRODOL — Supplemental Application (Wilshire Pharmaceuticals, Inc.)
The FDA approved a supplemental application for carisoprodol submitted by Wilshire Pharmaceuticals, Inc.
-
FDA approval · 2018-10-26FDA Approved: METHOCARBAMOL — Original Application (Sagent Pharmaceuticals)
FDA approved an original application for a generic methocarbamol product from Sagent Pharmaceuticals.
-
CLINICAL_TRIALS trial_result · 2018-06-27Clinical Trial Update: Active Prevention of Upper Limb Musculoskeletal Disorders in Thermal Environment (MUSKA). [NA]
The MUSKA trial, sponsored by Association Française pour la Recherche Thermale, studied active prevention of upper limb musculoskeletal diso…
-
CLINICAL_TRIALS trial_result · 2018-06-12Clinical Trial Update: Effect of an Exercise Program Designed for Orchestral Musicians [NA]
The trial, sponsored by Laval University, completed a study evaluating an exercise program designed for orchestral musicians and its effect …
-
FDA approval · 2018-04-17FDA Approved: METHOCARBAMOL — Original Application (Fresenius Kabi USA, LLC)
FDA approved Fresenius Kabi USA, LLC's original application for a generic methocarbamol product (ANDA 209331), establishing a generic option…
-
FDA approval · 2017-07-31FDA Approved: METHOCARBAMOL — Original Application (Somerset Therapeutics, LLC)
FDA approved Somerset Therapeutics' original ANDA for methocarbamol (generic) for relief of discomfort associated with acute musculoskeletal…
-
FDA approval · 2017-06-15FDA Approved: METAXALONE — Original Application (Actavis Pharma, Inc.)
FDA approved Actavis Pharma, Inc.'s generic Metaxalone under an Original Application for relief of muscle spasm associated with musculoskele…